Sign in

You're signed outSign in or to get full access.

Beverly Goulet

Director at Xenia Hotels & Resorts
Board

About Beverly K. Goulet

Beverly K. Goulet (age 70) is an independent director of Xenia Hotels & Resorts (XHR) and serves as Chair of the Audit Committee and a member of the Executive Committee. She has been on the Board since Xenia’s NYSE listing in February 2015 (10 years of service), bringing senior executive experience from American Airlines, restructuring expertise, corporate finance, and legal training (BA and JD, University of Michigan) .

Past Roles

OrganizationRoleTenureNotes
American Airlines Group Inc.Senior Vice President & Chief Integration OfficerFeb 2013 – Nov 2015Led integration; prior Chief Restructuring Officer (2011–2013)
American Airlines Group Inc.Executive Vice President & Chief Integration OfficerDec 2015 – Jun 2017 (retired)Executive leadership through integration completion
American AirlinesChief Restructuring Officer2011 – 2013Led restructuring during Chapter 11
American AirlinesVice President—Corporate Development & Treasurer2002 – 2013Corporate finance and capital markets leadership
Law practiceCorporate & securities attorney~13 years (pre-2002)Legal/regulatory expertise

External Roles

OrganizationRoleTenureCommittees/Impact
Rolls‑Royce plcDirectorSince Jul 2017Global industrial governance; aviation ecosystem insight
Atlas Air WorldwideDirectorMay 2021 – Mar 2023Air cargo industry oversight

Board Governance

  • Committee assignments: Audit Committee (Chair) and Executive Committee (Member) .
  • Independence/financial expertise: Independent director; all Audit Committee members are “audit committee financial experts” per SEC definition and financially literate per NYSE standards .
  • Attendance and engagement: Board met 7 times in 2024; Audit and Compensation Committees each met 5 times; Nominating & Governance met 5 times. No incumbent director attended fewer than 75% of meetings; aggregate director attendance exceeded 99% .
  • Lead independent director/executive sessions: Independent directors hold executive sessions at each regularly scheduled Board meeting; Lead Director (Dennis Oklak) presides .
  • Ownership alignment policies: Director stock ownership guideline = 5x annual base retainer; all directors/NEOs in compliance or expected to meet within prescribed periods . Anti‑hedging and anti‑pledging policies apply to directors (no hedging or pledging permitted) .
  • Related‑party controls: Formal related person transaction policy with Audit Committee approval/ratification requirements under MGCL and Company bylaws .

Meeting & Attendance Snapshot (2024)

MetricValue
Board meetings held7
Audit Committee meetings5
Compensation Committee meetings5
Nominating & Governance Committee meetings5
Executive Committee meetings0
Incumbents <75% attendanceNone
Aggregate director attendance>99%

Committee Assignments (B. Goulet)

CommitteeRoleNotes
Audit CommitteeChairFinancial expert; oversees integrity of financials, auditor independence, internal audit, and cyber risk
Executive CommitteeMemberCan act on Board’s behalf between meetings (subject to limitations)

Fixed Compensation

Component2024 Amount
Annual cash retainer (non‑employee director)$75,000
Additional retainer – Audit Committee Chair$20,000
Fees earned in cash (actual)$95,000

Performance Compensation

Equity Award TypeGrant DateUnitsGrant‑date Fair Value
LTIP Units (fully vested on grant)2024 (Annual meeting)6,766$100,001

Director equity is fully vested at grant; annual grants are generally LTIP Units valued at ~$100,000 for re‑elected directors, with initial appointments receiving $100,000 in common stock (pro‑rated if mid‑year) .

Company Performance Metrics (NEO annual bonus – governance oversight context, 2024)

MetricThresholdTargetMaximumActualWeight
Adjusted FFO per share$1.298 $1.708 $2.118 $1.590 55%
Hotel EBITDA Margin23.1% 26.1% 29.1% 24.7% 15%
RevPAR$167.48 $176.30 $185.11 $172.36 10%
Individual objectivesVaries Varies Varies Max achieved 20%

Other Directorships & Interlocks

CompanyIndustry Link to XHRPotential Interlock/Conflict Considerations
Rolls‑Royce plcAviation OEM; indirectly connected to travel ecosystemNot a supplier/customer to XHR; low direct conflict risk
Atlas Air Worldwide (former)Air cargo; adjacent to air travelNo direct XHR linkage; tenure ended Mar 2023

Expertise & Qualifications

  • Public company board experience; corporate governance/ethics; legal/regulatory; risk management; accounting; capital markets; strategic planning; M&A; executive leadership; operational; HR/compensation; travel & lodging .
  • Legal credentials (JD, University of Michigan); restructuring leadership; corporate development/treasury experience .

Equity Ownership

MeasureValueNotes
Total beneficial ownership (shares)61,373Includes LTIP units redeemable into common stock under conditions
% of shares outstanding<1%Asterisk in proxy denotes less than 1%
LTIP Units included57,723LTIP Units fully vested on grant date count toward ownership
Shares pledged as collateralNoneProxy notes no pledged shares for directors/nominees
Ownership guideline5x annual base retainerApplies to non‑employee directors
Guideline compliance statusIn compliance or expected to meetCompany states all are compliant or on track within required timelines

Governance Assessment

  • Signals of effectiveness: Audit Chair role and financial expert designation; strong attendance; independent executive sessions; robust ownership and anti‑hedging/pledging policies support alignment and oversight quality .
  • Compensation alignment: Director pay balanced ($95k cash + ~$100k equity in 2024), with equity fully vested and ownership guidelines at 5x retainer, promoting skin‑in‑the‑game without complex performance gates for directors .
  • Potential conflicts: External boards (Rolls‑Royce, formerly Atlas Air) do not present apparent related‑party exposure to XHR; related person transactions require Audit Committee review/approval under formal policy .
  • Shareholder confidence indicators: Strong say‑on‑pay approval (over 97% in 2024); established proxy access and majority voting; independent standing committees; no poison pill; anti‑pledging/hedging; clawback policy—collectively supportive of investor confidence .